跳至主要内容
临床试验/ACTRN12612000271808
ACTRN12612000271808已完成4 期

Hemostatic effects of levothyroxine and selenomethionine in euthyroid women with Hashimoto's thyroiditis: a six-month single-center, randomized, double-blind, placebo-controlled study

the Polish Committee of Scientific Research0 个研究点目标入组 155 人开始时间: 2012年3月7日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
155

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
Female

入选标准

  • (a) positive antibodies (>100 U/mL) against thyroid peroxidase (TPOAb), (b) the reduced echogenicity of the thyroid parenchyma on thyroid ultrasonography, (c) serum TSH less than 4.0 mU/L, and (d) plasma levels of free thyroxine (fT4) and free triiodothyronine (fT3)) within the reference range

排除标准

  • A) any acute and chronic inflammatory processes
  • B) other autoimmune disorders
  • C) positive serum antibodies against TSH receptor
  • D) current treatment with thyroid hormones
  • E) concomitant treatment with drugs that may affect inflammatory processes in the vascular wall
  • F) concomitant treatment with other drugs known either to affect thyroid hormones or to interact with levothyroxine and selenomethionine
  • G) BMI>40 kg/m2
  • H) Turner or Down syndrome
  • I) any form of coronary artery disease
  • J) moderate or severe arterial hypertension (ESC/ESH grade 2 or 3)
  • K) symptomatic congestive heart failure
  • L) diabetes, impaired glucose tolerance or impaired fasting glucose
  • M) impaired renal or hepatic function
  • N) pregnancy or lactation
  • O) poor patient compliance

研究者

发起方
the Polish Committee of Scientific Research

相似试验